Pharmacovigilance and Drug Safety: Current Trends and Research

Pharmacovigilance, the science and activities related to detecting, assessing, understanding, and preventing adverse effects or any other drug-related problems, has become an indispensable component of healthcare systems worldwide. As new drugs continue to emerge and as healthcare practices evolve, ensuring the safety and efficacy of these medications is paramount. The landscape of drug safety is constantly changing, with advancements in research, new regulatory frameworks, and increasing patient diversity influencing how we monitor and manage the risks associated with drug use.
Pharmacovigilance and Drug Safety: Current Trends and Research provides a comprehensive exploration of the rapidly evolving field of pharmacovigilance. This book delves into the current state of drug safety practices, drawing from the latest research and real-world case studies to offer insights into pharmacovigilance’s challenges and opportunities. From pre-market safety evaluations to post-market surveillance and risk management, the chapters in this volume explore the intricate processes involved in safeguarding public health.
The book covers a broad range of topics, including integrating big data and AI in adverse event reporting, the role of regulatory agencies, signal detection, pharmacoepidemiology, and the growing importance of patient-centered approaches. Furthermore, it highlights emerging trends, such as personalized medicine and the safety concerns surrounding biologics and biosimilars, that are reshaping how we approach drug safety.
This work is intended for pharmaceutical professionals, researchers, clinicians, regulatory experts, and students in pharmacology, toxicology, and healthcare. By bringing together a wealth of current research and expert perspectives, Pharmacovigilance and Drug Safety is a vital reference and a source of inspiration for those committed to improving patient safety and advancing drug development.
We hope this book will contribute to the ongoing dialogue and research in pharmacovigilance, fostering a deeper understanding of the evolving landscape of drug safety in the global healthcare system.